Jonathan Dixon
Consigliere Generale presso BIONANO GENOMICS, INC.
Patrimonio netto: 17 448 $ in data 31/05/2024
Profilo
Jonathan Dixon is currently working as the Secretary & General Counsel at Bionano Genomics, Inc. He previously worked as the Legal Director at GeneOhm Sciences, Inc., and as an Associate General Counsel at Becton, Dickinson & Co. and CareFusion Corp.
He completed his undergraduate degree at Brigham Young University and his graduate degree at Lewis & Clark Law School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BIONANO GENOMICS, INC.
0.03% | 03/06/2024 | 18 025 ( 0.03% ) | 17 448 $ | 31/05/2024 |
Posizioni attive di Jonathan Dixon
Società | Posizione | Inizio |
---|---|---|
BIONANO GENOMICS, INC. | Consigliere Generale | 01/03/2022 |
Precedenti posizioni note di Jonathan Dixon
Società | Posizione | Fine |
---|---|---|
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
CAREFUSION CORPORATION | Corporate Officer/Principal | - |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Direttore/Membro del Consiglio | - |
Formazione di Jonathan Dixon
Brigham Young University | Undergraduate Degree |
Lewis & Clark Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIONANO GENOMICS, INC. | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
Aziende private | 2 |
---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
CareFusion Corp.
CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |
- Borsa valori
- Insiders
- Jonathan Dixon